Raphael J. Mannino - Sep 3, 2021 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role
Chief Scientific Officer
Signature
/s/ Keith A. Kucinski, attorney in fact for Raphael J. Mannino
Stock symbol
MTNB
Transactions as of
Sep 3, 2021
Transactions value $
$0
Form type
4
Date filed
9/14/2021, 05:30 PM
Previous filing
Jun 24, 2021
Next filing
Dec 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTNB Common Stock, par value $0.0001 per share Other $0 +462K +31.71% $0.00 1.92M Sep 3, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received pursuant to an amendment to the Agreement and Plan of Merger dated as of January 29, 2015 by an among the Issuer, Saffron Merger Sub, Inc. and Aquarius Biotechnologies Inc.